Transparency Market Research
Interventional electrophysiology has made remarkable advancements in the last decade. Cardiac mapping is one of the highly advanced processes associated with the collection and display of data gathered from an electrocardiogram. It is characterized as a process involving the identification of spatial and temporal distribution of myocardial electrical signals during a particular heart rhythm. The information collected is transmitted to the software, where a 3-dimentional (3D) model of the heart is created, showing the electric waves generated during each heartbeat. The technique shows the location and movement of the catheter inside the heart. The simple procedure of cardiac mapping allows physicians to accurately pinpoint the location of heart chambers that are experiencing arrhythmia.
Introduction of numerous advanced diagnostic technologies by medical device companies, rise in demand for the precise diagnosis of critical cardiac diseases, and availability of well-qualified interventional cardiologists in developed economies are expected to augment the expansion of the cardiac mapping systems market during the forecast period. However, lack of awareness about cardiac mapping systems in developing countries, their high cost, and the criticalities associated with the procedure of cardiac mapping are projected to be major restraints of the cardiac mapping systems market in the near future.
The global cardiac mapping systems market can be segmented based on technology, end-user, and region. Based on technology, the global cardiac mapping systems market can be categorized into contact mapping systems and non-contact mapping systems. The contact mapping systems segment accounted for a prominent market share in terms of revenue in 2017 and is expected to continue to remain dominant throughout the forecast period. Rise in incidence of cardiovascular diseases among all age groups owing to a sedentary lifestyle and rise in obesity and the involvement of key companies, such as Abbott and Medtronic, in the manufacture of contact mapping systems are estimated to augment the expansion of contact mapping systems market during the forecast period. Introduction of cardiac mapping systems without catheters by companies such as Medtronic, specifically for ventricular tachycardia (VT) and supraventricular tachycardia (SVTs), are projected to fuel the non-contact mapping systems segment in the coming years.
In terms of end-user, the global cardiac mapping systems market can be categorized into hospitals, ambulatory surgical centers, clinics, and others. Rise in investment by public and private players in multispecialty hospitals with an aim to improve health care infrastructure and increase in adoption for advanced and precise diagnostic tools by interventional cardiologists in hospitals were key factors for the dominance of the hospitals segment in global cardiac mapping systems market in terms of revenue in 2017. The segment is expected to maintain its leading position throughout the forecast period due to significant prevalence of cardiac arrhythmias and rise in awareness about them in emerging countries. However, the clinics segment is estimated to expand at a comparatively higher CAGR between 2018 and 2026, owing to a rise in demand by patients for cost-effective diagnosis and treatment for cardiovascular diseases and improved reimbursement policies across the globe.
In terms of region, the global cardiac mapping systems market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a prominent market share in 2017, which is attributed to the flexible management of patients in U.S. hospitals and favorable reimbursement policies for cardiovascular diseases. The region is expected to remain dominant throughout the forecast period, due to the integration of technology with health care in health care facilities in North America. Europe is estimated to constitute key market share during the forecast period. Rise in the number of interventional cardiologists in India and Australia is increasing awareness about cardiac mapping systems in those countries. This is considered to be a key factor for the estimated expansion of the market in Asia Pacific at a relatively significant CAGR during the forecast period.
Major players operating in the global cardiac mapping systems market include Abbott, Medtronic, Biosense Webster, Inc., Boston Scientific Corporation, Kardium, Inc., Lepu Medical, Catheter Robotics, Inc., and EP Solutions SA.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.